1. Home
  2. LGND vs PII Comparison

LGND vs PII Comparison

Compare LGND & PII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • PII
  • Stock Information
  • Founded
  • LGND 1987
  • PII 1954
  • Country
  • LGND United States
  • PII United States
  • Employees
  • LGND N/A
  • PII N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • PII Recreational Games/Products/Toys
  • Sector
  • LGND Health Care
  • PII Consumer Discretionary
  • Exchange
  • LGND Nasdaq
  • PII Nasdaq
  • Market Cap
  • LGND 2.0B
  • PII 1.9B
  • IPO Year
  • LGND 1992
  • PII 1987
  • Fundamental
  • Price
  • LGND $102.19
  • PII $39.25
  • Analyst Decision
  • LGND Strong Buy
  • PII Hold
  • Analyst Count
  • LGND 8
  • PII 12
  • Target Price
  • LGND $144.71
  • PII $41.60
  • AVG Volume (30 Days)
  • LGND 118.3K
  • PII 1.5M
  • Earning Date
  • LGND 05-08-2025
  • PII 07-22-2025
  • Dividend Yield
  • LGND N/A
  • PII 6.83%
  • EPS Growth
  • LGND N/A
  • PII N/A
  • EPS
  • LGND N/A
  • PII 0.71
  • Revenue
  • LGND $181,488,000.00
  • PII $7,072,600,000.00
  • Revenue This Year
  • LGND $17.68
  • PII N/A
  • Revenue Next Year
  • LGND $18.69
  • PII $3.92
  • P/E Ratio
  • LGND N/A
  • PII $55.37
  • Revenue Growth
  • LGND 53.40
  • PII N/A
  • 52 Week Low
  • LGND $77.43
  • PII $30.92
  • 52 Week High
  • LGND $129.90
  • PII $88.00
  • Technical
  • Relative Strength Index (RSI)
  • LGND 44.63
  • PII 55.79
  • Support Level
  • LGND $98.90
  • PII $37.50
  • Resistance Level
  • LGND $103.17
  • PII $41.73
  • Average True Range (ATR)
  • LGND 3.05
  • PII 1.57
  • MACD
  • LGND -0.27
  • PII 0.22
  • Stochastic Oscillator
  • LGND 31.94
  • PII 44.02

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About PII Polaris Inc.

Polaris designs and manufactures off-road vehicles, including all-terrain vehicles and side-by-side vehicles for recreational and utility purposes, snowmobiles, and on-road vehicles, including motorcycles, along with the related replacement parts, garments, and accessories. The firm entered the marine market after acquiring Boat Holdings in 2018, offering exposure to another segment of the outdoor lifestyle market. Polaris products are retailed through more than 2,500 dealers in North America and 1,500 international dealers as well as more than 25 subsidiaries and 90 distributors in more than 100 countries outside North America.

Share on Social Networks: